Literature DB >> 9316654

Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in normal and malignant human prostate.

K T Perry1, C T Anthony, M S Steiner.   

Abstract

BACKGROUND: Prostate cancer eventually becomes androgen-independent, suggesting that growth factors such as TGF beta 1-3 may potentially contribute to prostate neoplasia. The pattern and level of TGF beta 1-3 protein expression in normal and malignant human prostate are unknown.
METHODS: An immunohistochemical study was undertaken to analyze TGF beta 1, TGF beta 2, and TGF beta 3 protein in malignant and adjacent normal prostates from 25 patients who had clinically localized prostate cancer.
RESULTS: Normal prostate exhibited similar TGF beta 1 immunostaining in stromal and epithelial cells, whereas TGF beta 2 and TGF beta 3 protein staining was greater in the epithelial relative to the stromal compartments. In malignancy, prostate epithelial cells had higher TGF beta 1 and TGF beta 2 immunostaining than either the surrounding stromal cells or their normal prostatic epithelial counterparts. Although TGF beta 3 staining intensity was similar for both malignant and normal prostate epithelial cells, the pattern of staining switched from uniform apical to diffuse protein staining in malignant prostate glands.
CONCLUSIONS: Prostate cancer was associated with alterations of TGF beta 1, TGF beta 2, and TGF beta 3 expression by prostatic epithelial cells which may play a role in prostatic carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316654     DOI: 10.1002/(sici)1097-0045(19971001)33:2<133::aid-pros7>3.0.co;2-l

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  14 in total

1.  Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.

Authors:  Andrew J Stephenson; Alex Smith; Michael W Kattan; Jaya Satagopan; Victor E Reuter; Peter T Scardino; William L Gerald
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

2.  The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones.

Authors:  Qi Jiang; Bang-Min Han; Fu-Jun Zhao; Yan Hong; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

3.  [Transforming growth factor β in prostate cancer: cellular effects and basic molecular mechanisms].

Authors:  M B Stope; C Rönnau; T Schubert; D Staar; J Bradl; P Ziegler; A Streitbörger; N Kroeger; U Zimmermann; R Walther; M Burchardt; C Börgermann
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

4.  A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.

Authors:  Eswar Shankar; Kyung Song; Sarah L Corum; Kara L Bane; Hui Wang; Hung-Ying Kao; David Danielpour
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

Review 5.  Roles for the type III TGF-beta receptor in human cancer.

Authors:  Catherine E Gatza; Sun Young Oh; Gerard C Blobe
Journal:  Cell Signal       Date:  2010-02-12       Impact factor: 4.315

6.  Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors.

Authors:  Feng Sun; He-ge Chen; Wei Li; Xi Yang; Xin Wang; Richeng Jiang; Zhiyong Guo; Hegang Chen; Jiaoti Huang; Alexander D Borowsky; Yun Qiu
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

7.  Prostate cancer markers: An update.

Authors:  Srinivas Pentyala; Terry Whyard; Sahana Pentyala; John Muller; John Pfail; Sunjit Parmar; Carlos G Helguero; Sardar Khan
Journal:  Biomed Rep       Date:  2016-01-29

8.  Expression, purification and characterization of BG(E)RII: a novel pan-TGFbeta inhibitor.

Authors:  Erik V Verona; Yuping Tang; Thomas K Millstead; Andrew P Hinck; Joseph K Agyin; Lu-Zhe Sun
Journal:  Protein Eng Des Sel       Date:  2008-05-21       Impact factor: 1.650

Review 9.  Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.

Authors:  Arich Ryan Reynolds; Natasha Kyprianou
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

10.  Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor.

Authors:  Yuanjie Niu; Juan Wang; Zhiqun Shang; Shu-Pin Huang; Chih-Rong Shyr; Shuyuan Yeh; Chawnshang Chang
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.